Charalambos Solomides
- Molecular Biology top 10%
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Surgery top 10%
- Co-authors
- Melpo Christofidou‐SolomidouEvguenia ArguiriSteven Μ. AlbeldaMarluce BibboVladimir R. MuzykantovStephen C. PeiperKeith A. CengelJing Sun
- Topics
- Pancreatic and Hepatic Oncology Research (10 papers)Cancer Genomics and Diagnostics (7 papers)Neuroendocrine Tumor Research Advances (6 papers)
- Journals
- Journal of Biological ChemistryJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- United StatesChinaSlovakia
In The Last Decade
Charalambos Solomides
87 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Biology 1.1k
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 746
- Cancer Research 598
- Surgery 484
Countries citing papers authored by Charalambos Solomides
This map shows the geographic impact of Charalambos Solomides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charalambos Solomides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charalambos Solomides more than expected).
Fields of papers citing papers by Charalambos Solomides
This network shows the impact of papers produced by Charalambos Solomides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charalambos Solomides. The network helps show where Charalambos Solomides may publish in the future.
Co-authorship network of co-authors of Charalambos Solomides
This figure shows the co-authorship network connecting the top 25 collaborators of Charalambos Solomides. A scholar is included among the top collaborators of Charalambos Solomides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charalambos Solomides. Charalambos Solomides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 41 | |
| 3 | 10 | |
| 4 | 24 | |
| 5 | 15 | |
| 6 | 37 | |
| 7 | 4 | |
| 8 | 44 | |
| 9 | Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicitybreakdown → | 515 |
| 10 | 3 | |
| 11 | 15 | |
| 12 | 5 | |
| 13 | 115 | |
| 14 | 48 | |
| 15 | 32 | |
| 16 | 27 | |
| 17 | 46 | |
| 18 | 2 | |
| 19 | 52 | |
| 20 | Semiquantitative assessment of c-erbB-2 (HER-2) status in cytology specimens and tissue sections from breast carcinoma. | 17 |
About Charalambos Solomides
Charalambos Solomides is a scholar working on Oncology, Cancer Research and Otorhinolaryngology, having authored 89 papers that have together received 3.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (10 papers), Cancer Genomics and Diagnostics (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Cancer Research (598 citations), Oncology (1.0k citations) and Pulmonary and Respiratory Medicine (746 citations). Charalambos Solomides has collaborated with scholars based in United States, China and Slovakia. Frequent co-authors include Melpo Christofidou‐Solomidou, Evguenia Arguiri, Steven Μ. Albelda, Marluce Bibbo, Vladimir R. Muzykantov, Stephen C. Peiper, Keith A. Cengel, Jing Sun, Ellen Puré and John Scholler. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.